Catalent Inc logo

Catalent Inc CTLT

Market Closed
18 Jun, 20:00
NYSE NYSE
$
55. 07
-0.14
-0.25%
Pre Market
$
55. 00
-0.07 -0.13%
10.13B Market Cap
- P/E Ratio
0% Div Yield
986,400 Volume
1.01 Eps
$ 55.21
Previous Close
Day Range
55.03 55.3
Year Range
31.8 60.2

CTLT Chart

Catalent Inc Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Alessandro Maselli CEO
NYSE Exchange
US1488061029 ISIN
US Country
18,000 Employees
- Last Dividend
- Last Split
31 Jul 2014 IPO Date

Overview

Catalent, Inc. is a global leader in delivering innovative solutions for drug development, biologic therapeutics, and consumer health products. With its foundation dating back to 1933, Catalent prides itself on its comprehensive expertise in advancing molecules, biologics, and consumer health products from early development to full-scale production. The company operates through two main segments: Biologics, and Pharma and Consumer Health, providing a broad spectrum of services worldwide. Catalent is committed to serving the pharmaceutical, biotechnology, consumer health, animal health, medical devices, and cosmetics industries. Headquartered in Somerset, New Jersey, Catalent stands as a pivotal partner for companies in various healthcare sectors, facilitating the pathway from laboratory to market.

Products and Services

Biologics Segment Services:

  • Biologic Protein, Cell, and Gene Therapy Development: Offers formulation, development, and manufacturing services for a broad range of therapeutics including biologic proteins, cell gene therapies, pDNA, iPSCs, oncolytic viruses, and vaccines.
  • Parenteral Dose Forms Manufacturing: Specializes in formulation, development, and manufacturing for parenteral dose forms such as vials, prefilled syringes, and cartridges.
  • Large Molecule Analytical Development and Testing: Provides analytical development and testing services, focusing on large molecules.

Pharma and Consumer Health Segment Services:

  • Soft Capsule Development and Manufacturing: Offers formulation, development, and manufacturing services for soft capsules utilized in prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
  • Diverse Dose Forms Development and Manufacturing: Provides services for the development and manufacturing of oral, nasal, inhaled, and topical dose forms.
  • Clinical Supply Services: Offers manufacturing, packaging, storage, distribution, and inventory management for clinical trials, covering small-molecule drugs, protein-based biologics, and cell and gene therapies.
  • Pre-Clinical and Commercial Scale Manufacturing: Supplies pre-clinical screening, formulation, analytical development, and cGMP manufacturing services for a variety of formats including softgel capsules, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices.

Additional Services and Solutions:

  • Direct-to-Patient and Demand-Led Clinical Supply Solutions: Catalent offers FlexDirect and FastChain services for innovative and flexible clinical supply and distribution.
  • Fill and Finish Operations for Injectables: Provides specialized fill and finish operations for injectable products, ensuring quality and efficiency in the final stages of pharmaceutical manufacturing.
  • Integrated Development and Supply Chain Solutions: Offers comprehensive solutions that streamline the product development lifecycle, from development through to supply chain optimization.

Contact Information

Address: 14 Schoolhouse Road, Somerset, NJ, United States, 08873
Phone: 732 537 6200